Patents by Inventor Carol De La motte

Carol De La motte has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Composition and method to enhance expression of human defensin 2
    Patent number: 10653714
    Abstract: Compositions and methods are provided for enhancing the expression of human beta defensin 2 (HBD2) in human colon epithelium cells. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.
    Type: Grant
    Filed: October 31, 2017
    Date of Patent: May 19, 2020
    Assignee: The Cleveland Clinic Foundation
    Inventors: Carol de la Motte, Sean Kessler, David Richard Hill
  • COMPOSITION AND METHOD TO ENHANCE EXPRESSION OF HUMAN DEFENSIN 2
    Publication number: 20180117078
    Abstract: Compositions and methods are provided for enhancing the expression of human beta defensin 2 (HBD2) in human colon epithelium cells. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.
    Type: Application
    Filed: October 31, 2017
    Publication date: May 3, 2018
    Inventors: Carol de la MOTTE, Sean KESSLER, David Richard HILL
  • COMPOSITION AND METHOD TO IMPROVE INTESTINAL HEALTH
    Publication number: 20140072621
    Abstract: Compositions and methods are provided for treating patients suffering from compromised intestinal function, including inflammatory bowel disease. The method comprises orally administering a composition comprising hyaluronan, where said hyaluronan has a molecular weight within the range of about 35 kDa.
    Type: Application
    Filed: May 8, 2012
    Publication date: March 13, 2014
    Applicant: THE CLEVELAND CLINIC FOUNDATION
    Inventors: Carol De La motte, Sean Kessler